These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 33450487

  • 1. Ivabradine prevents deleterious effects of dopamine therapy in heart failure: No role for HCN4 overexpression.
    Paterek A, Sochanowicz B, Oknińska M, Śmigielski W, Kruszewski M, Mackiewicz U, Mączewski M, Leszek P.
    Biomed Pharmacother; 2021 Apr; 136():111250. PubMed ID: 33450487
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P, Messaoudi S, Nehme J, Rodriguez C, Samuel JL, Delcayre C.
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [Abstract] [Full Text] [Related]

  • 3. Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression.
    Wang J, Yang YM, Li Y, Zhu J, Lian H, Shao XH, Zhang H, Fu YC, Zhang LF.
    J Cardiovasc Electrophysiol; 2019 Feb; 30(2):242-252. PubMed ID: 30302853
    [Abstract] [Full Text] [Related]

  • 4. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C.
    Circulation; 2004 Apr 06; 109(13):1674-9. PubMed ID: 14981003
    [Abstract] [Full Text] [Related]

  • 5. Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.
    Suffredini S, Stillitano F, Comini L, Bouly M, Brogioni S, Ceconi C, Ferrari R, Mugelli A, Cerbai E.
    Br J Pharmacol; 2012 Mar 06; 165(5):1457-66. PubMed ID: 21838751
    [Abstract] [Full Text] [Related]

  • 6. Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report.
    Núñez L, Crespo-Leiro MG, Marrón-Liñares GM, Suarez-Fuentetaja N, Barge-Caballero E, Paniagua-Martín MJ, Marzoa-Rivas R, Grille-Cancela Z, Muñiz-García J, Vazquez-Rodriguez JM, Hermida-Prieto M.
    Cardiol J; 2016 Mar 06; 23(5):573-582. PubMed ID: 27439367
    [Abstract] [Full Text] [Related]

  • 7. Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation.
    Chobanyan-Jürgens K, Heusser K, Duncker D, Veltmann C, May M, Mehling H, Luft FC, Schröder C, Jordan J, Tank J.
    Sci Rep; 2018 May 17; 8(1):7748. PubMed ID: 29773827
    [Abstract] [Full Text] [Related]

  • 8. Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.
    Fang Y, Debunne M, Vercauteren M, Brakenhielm E, Richard V, Lallemand F, Henry JP, Mulder P, Thuillez C.
    J Cardiovasc Pharmacol; 2012 Mar 17; 59(3):260-7. PubMed ID: 22075752
    [Abstract] [Full Text] [Related]

  • 9. Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model.
    Zicha S, Fernández-Velasco M, Lonardo G, L'Heureux N, Nattel S.
    Cardiovasc Res; 2005 Jun 01; 66(3):472-81. PubMed ID: 15914112
    [Abstract] [Full Text] [Related]

  • 10. Ivabradine restores tonic cardiovascular autonomic control and reduces tachycardia, hypertension and left ventricular inflammation in post-weaning protein malnourished rats.
    Guedes MR, de Noronha SISR, Chírico MTT, da Costa GDC, de Freitas Castro T, de Brito RCF, Vieira LG, Reis TO, Ribeiro MC, Reis AB, Carneiro CM, Bezerra FS, Montano N, da Silva VJD, de Menezes RCA, Chianca-Jr DA, Silva FCDS.
    Life Sci; 2024 Jun 01; 346():122636. PubMed ID: 38614307
    [Abstract] [Full Text] [Related]

  • 11. Preclinical results with I(f) current inhibition by ivabradine.
    Berdeaux A.
    Drugs; 2007 Jun 01; 67 Suppl 2():25-33. PubMed ID: 17999561
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model.
    Chang PC, Lin SF, Chu Y, Wo HT, Lee HL, Huang YC, Wen MS, Chou CC.
    Cardiovasc Ther; 2019 Jun 01; 2019():6032631. PubMed ID: 31772612
    [Abstract] [Full Text] [Related]

  • 15. Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.
    Kim BH, Cho KI, Kim SM, Kim N, Han J, Kim JY, Kim IJ.
    Heart Vessels; 2013 Jul 01; 28(4):524-35. PubMed ID: 23142972
    [Abstract] [Full Text] [Related]

  • 16. Ivabradine protects against ventricular arrhythmias in acute myocardial infarction in the rat.
    Mackiewicz U, Gerges JY, Chu S, Duda M, Dobrzynski H, Lewartowski B, Mączewski M.
    J Cell Physiol; 2014 Jun 01; 229(6):813-23. PubMed ID: 24590965
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.